Concierge Program · New Orleans & Metairie
Care for Lipedema & Inflammation, built around your metabolism
A physician-directed concierge program for people whose weight, swelling, and inflammation haven’t responded to ordinary dieting. We treat the biology — inflamed, fibrotic fat and a stressed metabolic system — not your willpower. GLP-1 medication is one tool inside a larger, monitored plan led by Jacques Courseault, MD.
· Physician-led · Slow, monitored titration · Anti-inflammatory nutrition · Fascia & lymphatic care · Genomic screening
01 · The Treatment Gap
When the diet works everywhere except where it matters
You’ve counted calories. You’ve trained. Your face and waist may have changed — but your legs, hips, and arms stay heavy, tender, and prone to bruising. That is not a failure of discipline. In lipedema and inflammation-driven fat, the tissue itself is biologically resistant to ordinary weight loss. Studies show that even when people lose weight, the affected fat’s underlying inflammation and fibrosis often don’t change — and lipedematous fat is famously resistant to caloric restriction, appetite suppressants, and even bariatric surgery.
Our starting point is simple: if the fat is inflamed and fibrotic, the plan has to treat inflammation and fibrosis — not just cut calories.
02 · The Biology
Inflamed fat behaves differently
Lipedema and inflammatory adiposity are driven by a mix of adipocyte enlargement, chronic low-grade inflammation, fibrosis, small-vessel and lymphatic dysfunction, and hormonal influence — often accelerating around puberty, pregnancy, and menopause. Interestingly, the immune signature differs from ordinary obesity: research points to a predominance of anti-inflammatory M2 macrophages and a distinct pattern of matrix and lymphatic change, which helps explain why the tissue swells, hurts, and resists mobilization in ways standard weight-loss advice never addresses.
Inflammation
Chronic tissue inflammation drives pain, tenderness, and easy bruising — and quietly resists fat loss.
Fibrosis
Scar-like tissue builds up around fat and lymphatics, constricting flow and locking the volume in place.
Metabolism
Impaired fat mobilization and mitochondrial strain mean the usual diet-and-exercise math simply doesn’t apply.
03 · The Concierge Approach
One physician, one coordinated plan
This is not a med-spa injection subscription. It is a concierge medical program directed by Jacques Courseault, MD — a fascia and connective-tissue specialist — where every lever that influences inflamed, resistant fat is coordinated under one roof, with genuine physician access between visits.
· Medical metabolic therapy — GLP-1 / dual-agonist medication when appropriate, via our physician-run FLIP program
· Anti-inflammatory nutrition — Mediterranean and therapeutic carbohydrate strategies shown to lower systemic inflammation in lipedema
· Fascia & lymphatic care — hands-on and Hydrofascia Release™ to address fibrosis and flow the deep tissue holds
· Genomic screening — the FIT GPS Genomic Performance Screen to personalize nutrition, medication response, and recovery
· Movement & recovery — structured, joint-friendly programming with objective OxeFit strength tracking
04 · Where GLP-1 Fits
A powerful tool — used carefully, not blindly
GLP-1 and dual GLP-1/GIP medications (semaglutide, tirzepatide) are best known for weight loss and blood-sugar control. What makes them interesting for this program is a second set of effects emerging in the research: anti-inflammatory, anti-fibrotic, and thermogenic (fat-remodeling) signals that line up with the biology of lipedema. Recent 2025 narrative reviews describe tirzepatide, in particular, as a promising candidate to address the metabolic and inflammatory terrain of lipedema — not just to shrink the scale number.
Our honest position: this evidence is still early, and these medications are not FDA-approved specifically for lipedema. That is exactly why they belong inside a monitored, physician-led program — with slow titration, monthly labs, muscle-preserving nutrition and training, and a plan for the affected tissue that medication alone can’t reach. GLP-1 is one instrument in the program, not the whole program.
If you also live with hypermobility, hEDS, or mast cell activation, read Dr. Courseault’s clinical commentary on GLP-1, mast cell activation, and the hypermobile body — connective-tissue-aware dosing is a core reason patients choose this program.
05 · What Concierge Means Here
Access, monitoring, and a plan that adjusts to you
Physician-led, not automated
Your plan is directed and adjusted by Dr. Courseault — with real access between visits, not a portal and a refill button.
Measured, not guessed
Monthly labs, body-composition and strength tracking, and inflammation markers keep the plan safe and steer every change.
The goal is muscle-sparing progress: protect lean tissue and strength while we lower inflammation, improve metabolic health, and address the fibrotic, fluid-holding fat that ordinary programs ignore.
06 · Is This Program For You?
You may be a fit if this sounds familiar
· Diet and exercise change your upper body but not your legs, hips, or arms
· Your lower body feels heavy, tender, or bruises easily
· You suspect lipedema, or have been told “just lose weight” without a real plan
· You want GLP-1 therapy done safely, with monitoring — not from a pop-up clinic
· You’re managing inflammation, hormonal shifts (including menopause), or connective-tissue conditions alongside weight
Wherever you are on the spectrum — early, advanced, or simply unsure — you’re welcome here. We meet you where you are and build from your biology, not a label.
07 · How It Works
Your first three months, step by step
1 · Consultation & workup. A full history, physical, and baseline labs. We map inflammation, metabolic health, and — when useful — genomics through FIT GPS.
2 · Your plan. Together we decide whether GLP-1 therapy is appropriate, and pair it with anti-inflammatory nutrition, fascia/lymphatic care, and a movement plan built around your joints.
3 · Monitored titration. If medication is used, we start low and go slow, with monthly labs and check-ins to protect muscle and manage side effects.
4 · Adjust & sustain. We track strength, body composition, and symptoms, and adapt the plan for durable, muscle-sparing results — not a crash.
This page is for education and is not medical advice. GLP-1 and dual-agonist medications are not FDA-approved specifically for lipedema; their use for inflammation-related adiposity is emerging and individualized. Suitability, benefits, and risks are determined during a physician evaluation. Results vary. The Fascia Institute and Treatment Center®, 2520 Harvard Ave Ste 2B, Metairie, LA 70001 · (504) 704-1254.
